Stereotaxis Inc (STXS)

Currency in USD
1.940
+0.090(+4.86%)
Closed·
1.890-0.050(-2.58%)
·
STXS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.8401.985
52 wk Range
1.7403.590
Key Statistics
Prev. Close
1.94
Open
1.85
Day's Range
1.84-1.985
52 wk Range
1.74-3.59
Volume
495.74K
Average Volume (3m)
420.14K
1-Year Change
-5.3659%
Book Value / Share
0.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STXS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.125
Upside
+112.63%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Stereotaxis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.125
(+112.63% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Buy3.50+80.41%4.00Maintain13/05/2026
Citizens
Buy4.00+106.19%-Maintain01/04/2026
Citizens
Buy4.00+106.19%-New Coverage16/12/2025

Stereotaxis Inc Earnings Call Summary for Q1/2026

  • Stereotaxis Q1 2026 revenue fell 27.87% below forecast to $6.3M; EPS of -$0.06 missed estimates by 20%, triggering 3.72% stock decline to $1.81.
  • Total revenue dropped 15.9% YoY due to strategic shift from Johnson & Johnson catheters to proprietary MAGiC catheter, temporarily impacting recurring revenue.
  • Operating loss widened to $6.0M from $5.9M YoY; gross margin held at 60% despite production constraints limiting new product revenue realization.
  • Company targets 500 catheters/month production by end-2026; new MAGiC catheter and Synchrony Digital Surgery Cockpit expected to drive future growth.
  • Stock trades near 52-week low of $1.74, down 18% YTD; analysts maintain $4-$5 price targets, suggesting potential 100%+ upside despite near-term challenges.
Last Updated: 12/05/2026, 22:26
Read Full Transcript

Earnings

Latest Release
12/05/2026
EPS / Forecast
-0.06 / -0.05
Revenue / Forecast
6.29M / 8.72M
EPS Revisions
Last 90 days

Compare STXS to Peers and Sector

Metrics to compare
STXS
Peers
Sector
Relationship
P/E Ratio
−7.9x−3.5x−0.5x
PEG Ratio
−0.51−0.180.00
Price/Book
13.4x3.7x2.6x
Price / LTM Sales
5.6x2.7x3.2x
Upside (Analyst Target)
108.3%43.4%50.4%
Fair Value Upside
Unlock19.0%7.2%Unlock

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
9.62M9.87%17.80M
Other Institutional Investors
37.89M38.87%70.09M
Public Companies & Retail Investors
49.97M51.26%92.44M
Total
97.48M100.00%180.33M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dafna Capital Management, LLC14.03%13,680,55425,309
Lagoda Investment Management, L.P.4.99%4,861,2008,993

People Also Watch

3.400
RZLT
+2.10%
1.040
BEAT
+2.97%
0.309
NOTV
-1.59%
2.760
SPRO
+13.11%
5.18
OPRX
+5.29%

FAQ

What Is the Stereotaxis (NYSE: STXS) Share Price Today?

The Stereotaxis stock price today is 1.940 USD.

What Stock Exchange Does Stereotaxis (STXS) Trade On?

Stereotaxis is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Stereotaxis?

The stock symbol (also called a 'ticker') for Stereotaxis is "STXS."

What Is the Current Stereotaxis Market Capitalisation?

As of today, Stereotaxis (NYSE: STXS) market cap is 189.610M USD.

What Is Stereotaxis's (STXS) Earnings Per Share (TTM)?

The Stereotaxis EPS is currently -0.245 (Trailing Twelve Months).

When Is the Next Stereotaxis Earnings Date?

Stereotaxis's next earnings report will be released on 11/08/2026.

Is STXS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Stereotaxis moving averages and other technical indicators, the daily buy/sell signal for STXS stock is Buy.

How Many Times Has Stereotaxis Stock Split?

Stereotaxis has split 2 times. (See the STXS stock split history page for full effective split date and price information.)

How Many Employees Does Stereotaxis Have?

Stereotaxis has 131 employees, based on their latest Companies House report.

What is the current trading status of Stereotaxis (NYSE: STXS)?

As of 15/05/2026, Stereotaxis (STXS) is trading at a share price of 1.940 USD, with a previous close of 1.940 USD. The stock has fluctuated within a day range of 1.840 USD to 1.985 USD, while its 52-week range spans from 1.740 USD to 3.590 USD.

What Is Stereotaxis (STXS) Price Target According to Analysts?

The average 12-month price target for Stereotaxis is 4.125 USD, with a high estimate of 5 USD and a low estimate of 3.5 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +112.63% Upside potential.

What Is the STXS Premarket Price?

STXS's last pre-market stock price is 1.890 USD. The pre-market share volume is 10.000, and the stock has decreased by -0.050, or -2.580%.

What Is the STXS After Hours Price?

STXS's last after hours stock price is 1.989 USD, the stock has decreased by 0.049, or 2.530%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.